prIME Downloadable Slides from the 2015 Hematologic Malignancies Demystified Series
Wendy Stock, MD
University of Chicago Medical Center
- Integrate new data from trials evaluating current treatment options for hematologic malignancies
- Employ recent data from trials investigating novel therapies and approaches for treatment of hematologic malignancies
This educational activity is supported by grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Gilead Sciences, Inc.; Janssen Biotech, Inc.; Novartis; Onyx Pharmaceuticals, Inc.; Pharmacyclics, Inc.; Seattle Genetics, Inc.; Sigma-Tau Pharmaceuticals, Inc.; and Spectrum Pharmaceuticals, Inc.